日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Immunopeptidomics Mapping of Listeria monocytogenes T Cell Epitopes in Mice

小鼠单核细胞增生李斯特菌 T 细胞表位的免疫肽组学图谱

Adillah Gul, Lecia L Pewe, Patrick Willems, Rupert Mayer, Fabien Thery, Caroline Asselman, Ilke Aernout, Rein Verbeke, Denzel Eggermont, Laura Van Moortel, Ellen Upton, Yifeng Zhang, Katie Boucher, Laia Miret-Casals, Hans Demol, Stefaan C De Smedt, Ine Lentacker, Lilliana Radoshevich, John T Harty, 

The T-cell-directed vaccine BNT162b4 encoding conserved non-spike antigens protects animals from severe SARS-CoV-2 infection

编码保守的非刺突蛋白抗原的T细胞靶向疫苗BNT162b4可保护动物免受严重的SARS-CoV-2感染。

Christina M Arieta ,Yushu Joy Xie ,Daniel A Rothenberg ,Huitian Diao ,Dewi Harjanto ,Shirisha Meda ,Krisann Marquart ,Byron Koenitzer ,Tracey E Sciuto ,Alexander Lobo ,Adam Zuiani ,Stefanie A Krumm ,Carla Iris Cadima Couto ,Stephanie Hein ,André P Heinen ,Thomas Ziegenhals ,Yunpeng Liu-Lupo ,Annette B Vogel ,John R Srouji ,Stephanie Fesser ,Kaushik Thanki ,Kerstin Walzer ,Theresa A Addona ,Özlem Türeci ,Uğur Şahin ,Richard B Gaynor ,Asaf Poran

Protection of cell therapeutics from antibody-mediated killing by CD64 overexpression

CD64 过表达保护细胞疗法免受抗体介导的杀伤。

Alessia Gravina ,Grigol Tediashvili ,Raja Rajalingam ,Zoe Quandt ,Chad Deisenroth ,Sonja Schrepfer ,Tobias Deuse

Development of mesothelioma-specific oncolytic immunotherapy enabled by immunopeptidomics of murine and human mesothelioma tumors

利用小鼠和人类间皮瘤肿瘤的免疫肽组学开发间皮瘤特异性溶瘤免疫疗法

Jacopo Chiaro # ,Gabriella Antignani # ,Sara Feola ,Michaela Feodoroff ,Beatriz Martins ,Hanne Cojoc ,Salvatore Russo ,Manlio Fusciello ,Firas Hamdan ,Valentina Ferrari ,Daniele Ciampi ,Ilkka Ilonen ,Jari Räsänen ,Mikko Mäyränpää ,Jukka Partanen ,Satu Koskela ,Jarno Honkanen ,Jussi Halonen ,Lukasz Kuryk ,Maria Rescigno ,Mikaela Grönholm ,Rui M Branca ,Janne Lehtiö ,Vincenzo Cerullo

Proteomic discovery of chemical probes that perturb protein complexes in human cells

蛋白质组学发现可扰乱人类细胞中蛋白质复合物的化学探针

Michael R Lazear,Jarrett R Remsberg,Martin G Jaeger,Katherine Rothamel,Hsuan-Lin Her,Kristen E DeMeester,Evert Njomen,Simon J Hogg,Jahan Rahman,Landon R Whitby,Sang Joon Won,Michael A Schafroth,Daisuke Ogasawara,Minoru Yokoyama,Garrett L Lindsey,Haoxin Li,Jason Germain,Sabrina Barbas,Joan Vaughan,Thomas W Hanigan,Vincent F Vartabedian,Christopher J Reinhardt,Melissa M Dix,Seong Joo Koo,Inha Heo,John R Teijaro,Gabriel M Simon,Brahma Ghosh,Omar Abdel-Wahab,Kay Ahn,Alan Saghatelian,Bruno Melillo,Stuart L Schreiber,Gene W Yeo,Benjamin F Cravatt

A novel immunopeptidomic-based pipeline for the generation of personalized oncolytic cancer vaccines

基于免疫肽组学的新型个性化溶瘤癌症疫苗生成方法

Sara Feola, Jacopo Chiaro #, Beatriz Martins #, Salvatore Russo, Manlio Fusciello, Erkko Ylösmäki, Chiara Bonini, Eliana Ruggiero, Firas Hamdan, Michaela Feodoroff, Gabriella Antignani, Tapani Viitala, Sari Pesonen, Mikaela Grönholm, Rui M M Branca, Janne Lehtiö, Vincenzo Cerullo

Impact of tumor heterogeneity and microenvironment in identifying neoantigens in a patient with ovarian cancer

肿瘤异质性和微环境对卵巢癌患者新抗原识别的影响

Tao Dao #, Martin G Klatt #, Tatyana Korontsvit, Sung Soo Mun, Sean Guzman, Marissa Mattar, Oliver Zivanovic, Chrisann K Kyi, Nicholas D Socci, Roisin E O'Cearbhaill, David A Scheinberg

Immuno-transcriptomic profiling of extracranial pediatric solid malignancies

儿童颅外实体恶性肿瘤的免疫转录组分析

Andrew S Brohl,Sivasish Sindiri,Jun S Wei,David Milewski,Hsien-Chao Chou,Young K Song,Xinyu Wen,Jeetendra Kumar,Hue V Reardon,Uma S Mudunuri,Jack R Collins,Sushma Nagaraj,Vineela Gangalapudi,Manoj Tyagi,Yuelin J Zhu,Katherine E Masih,Marielle E Yohe,Jack F Shern,Yue Qi,Udayan Guha,Daniel Catchpoole,Rimas J Orentas,Igor B Kuznetsov,Nicolas J Llosa,John A Ligon,Brian K Turpin,Daniel G Leino,Shintaro Iwata,Irene L Andrulis,Jay S Wunder,Silvia R C Toledo,Paul S Meltzer,Ching Lau,Beverly A Teicher,Heather Magnan,Marc Ladanyi,Javed Khan

Identification of a class of non-conventional ER-stress-response-derived immunogenic peptides

鉴定一类非常规的内质网应激反应衍生的免疫原性肽

Alessia Melacarne ,Valentina Ferrari ,Luca Tiraboschi ,Michele Mishto ,Juliane Liepe ,Marina Aralla ,Laura Marconato ,Michela Lizier ,Chiara Pozzi ,Offer Zeira ,Giuseppe Penna ,Maria Rescigno

Low-dose CDK4/6 inhibitors induce presentation of pathway specific MHC ligands as potential targets for cancer immunotherapy

低剂量 CDK4/6 抑制剂诱导通路特异性 MHC 配体的呈递,作为癌症免疫治疗的潜在靶点

Angel Charles, Christopher M Bourne, Tanya Korontsvit, Zita E H Aretz, Sung Soo Mun, Tao Dao, Martin G Klatt, David A Scheinberg